期刊文献+

2,3-吡啶二甲酸和1,4-二咪唑基丁烷构筑的Cd(Ⅱ)配合物的合成、晶体结构及荧光性质(英文) 被引量:2

Synthesis, Crystal Structure and Luminescence Property of A Cd(Ⅱ) Coordination Polymer Constructed from 2,3-Pyridine Dicarboxylic Acid and 1,1′-(1,4-Butanediyl)bis(imidazole)
下载PDF
导出
摘要 合成了一个配位聚合物{[Cd(pdc)(bbi)]·2H2O}n(H2pdc=2,3-吡啶二甲酸,bbi=1,4-二咪唑基丁烷),利用元素分析、红外光谱和X-射线单晶衍射考察了配合物的结构。配合物中,Cd(Ⅱ)的配位数为5,每个Cd(Ⅱ)与1个吡啶二甲酸离子的1个羧基氧原子和吡啶氮原子,另1个吡啶二甲酸离子的1个羧基氧原子,以及2个1,4-二咪唑基丁烷的2个氮原子配位。吡啶二甲酸离子的配位方式可以表示为μ-(κ3N,O2∶O3),Cd(Ⅱ)与之连接形成一维骨架链[Cd(pdc)]∞。配体1,4-二咪唑基丁烷采用了"Ω"和"S"两种构型,它们进一步与中心原子配位形成三维网络结构。配合物为三重穿插的金刚石型网络结构,拓扑学符号为66。受光激发,该配合物在426 nm处有一个发射峰。 A coordination polymer, namely {[Cd(pdc)(bbi)] ·2HEO}n {H2pdc=2,3-pyridine dicarboxylic acid, bbi= 1,1'-(1,4-butanediyl)bis(imidazole)}, has been prepared and characterized by elemental analysis, IR spectrum, and single crystal X-ray diffraction. In the complex, each Cd(Ⅱ) is five-coordinated by one carboxylate O and one pyridyl N atoms from one pde anion, one carboxylate O atom from another pdc anion, and two N atoms from two bib ligands. The coordination mode of pde ligands are described as μ-(K^3N,O^2:O^3), and Cd atoms are bridged by them to form a 1D skeleton chain [Cd(pdc)]∞. The bbi ligands show "Ω" or "S" shaped conformations, and they further extend the structure into a 3D framework. The complex displays a 3-fold interpenetrating diamond framework with (66) topology. Under excitation, it can exhibit an emission peak at 426 nm.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2014年第7期1647-1652,共6页 Chinese Journal of Inorganic Chemistry
基金 河南省基础与技术前沿计划(No.142300410252) 河南省教育厅自然科学基金(No.13A150102) 河南省应用化学重点学科资助项目
关键词 2 3-吡啶二甲酸 1 4-二咪唑基丁烷 镉配合物 晶体结构 荧光 2,3-pyridine dicarboxylic acid 1,1'-(1,4-butanediyl)bis(imidazole) cadmium complex crystal structure luminescence
  • 相关文献

参考文献20

二级参考文献49

  • 1Kagan C R,Mitzi D B,Dimitrako-poulos E D.Science,1999,286:945-947.
  • 2Halasyamani P S,Drewitt M T,O'Hare D,Chem.Commun.,1997,9:867-870.
  • 3Chui S S Y,Lo M F,Charmant J P H,et al,Sciene.,1999,283:1148-1150.
  • 4Yin M C,Sun J T,J.Coord.Chem.,2005,58:335-342.
  • 5ZHANG Xingg-Jing(张兴晶),XING Yong-Heng(邢永恒),WANG Chun-Guang(王春光),et al.Chinese J.Inorg.Chem.(Wuji Huaxue Xuebao),2009,25(3):407-411.
  • 6Zhao B,Cheng P,Dai Y,et al.Angew.Chem.Int.Ed.,2003,42:934-936.
  • 7Zhou Y F,Jiang F L,Yuan D Q,et al.Angew.Chem.,Int.Ed.,2004,43:5665-5668.
  • 8Song Y S,Yan B,Weng,L H,Inorg.Chem.Commun.,2006,9:567-570.
  • 9Liang Y C,Cao R,Su W P,et al.Angew.Chem.,Int.Ed.,2000.39:3304-3307.
  • 10Liang Y C,Hong M C,Su W P,et al.Inorg.Chem.,2001,40:4574-4582.

共引文献5

同被引文献18

  • 1Alagesan L,Bhuvanesh N S P, Dharmaraj N. Dalton Trans., 2013,42:7210-7223.
  • 2Ye X P, Zhu T F, Wu W N, et al. Inorg. Chem. Commun., 2014,47:60-62.
  • 3Singh P, Singh D P, Singh V P. Polyhedron, 2014,81:56-65.
  • 4Nath M, Vats M, Roy P. Eur. J. Med. CAem., 2013,59:310-321.
  • 5Milenkovic M, Cantoni G,Bacchi A, et al. Polyhedron, 2014,80:47-52.
  • 6Milenkovic M,Bacchi A, Cantoni G, et al. Inorg. Chim. Acta, 2013,395:33-43.
  • 7Chang H Q,Jia L, Xu Z Q, et al. Inorg. Chem. Commun., 2015,57:8-10.
  • 8Li M X, Zhang L Z, Yang M, et al. Bioorg. Med. Chem. Lett. 2012,22:2418-2433.
  • 9Li M X, Zhang L Z, Zhang D, et al. Eur. J. Med. Chem., 2011,46:4383-4390.
  • 10WANG Zhao-Lu(王召璐),FENG Hui-Yim(冯慧云),LI Yan (李艳),et al.无机化学学报,2015, 31(10):2-7.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部